Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region

Description

List of Tables

The global gastric cancer diagnostics market size is expected to reach USD 2.78 billion by 2034, according to a new study by Polaris Market Research. The report "Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gastric cancer diagnostics market focuses on the various methods and technologies used to detect and confirm stomach cancer. This involves a range of medical tests, procedures, and evaluations that healthcare professionals use to identify the disease in its early stages, determine its spread, and guide appropriate treatment plans. These diagnostic approaches include imaging studies, endoscopic examinations, tissue biopsies, blood tests, and advanced molecular analyses, all aimed at providing an accurate and timely diagnosis.

The gastric cancer diagnostics market growth is attributed to the increasing number of gastric cancer cases around the world, which naturally leads to a higher demand for diagnostic services. Additionally, there is a growing emphasis on early detection through screening programs, as finding the cancer early often improves treatment success. The industry is also benefiting from ongoing technological advancements, with newer, more precise, and less invasive diagnostic tools becoming available, which helps identify the disease more effectively and tailoring treatments to individual patients.

Gastric Cancer Diagnostics Market Report Highlights

By product, the reagents & consumables segment held the largest share in 2024 as reagents and consumables are essential for almost every diagnostic test, from routine blood work to advanced molecular analyses.

By disease type, the adenocarcinoma segment held the largest share in 2024, due to its overwhelming prevalence as the most common form of gastric cancer. The majority of diagnostic efforts and resource allocation are naturally directed toward identifying and characterizing this widespread disease type.

By end use, the hospitals segment held the largest share in 2024 as they are the primary healthcare facilities where patients typically receive initial diagnoses, undergo endoscopic procedures, and access comprehensive diagnostic infrastructure.

The North America gastric cancer diagnostics market accounted for the largest share in 2024, due to advanced healthcare infrastructure, high awareness regarding early diagnosis, and a strong focus on precision medicine. The market in Asia Pacific is expanding rapidly, driven by the highest global incidence of gastric cancer, particularly in East Asian countries.

A few key players in the market include F. Hoffmann-La Roche Ltd.; Abbott Laboratories; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Illumina, Inc.; Myriad Genetics, Inc.; Mirxes Pte. Ltd.; Vela Diagnostics; BIOMERIEUX; and AI Medical Service Inc.

Polaris Market Research has segmented the gastric cancer diagnostics market report on the basis of product, disease type, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Reagents & Consumables

Instruments

By Disease Type Outlook (Revenue - USD Billion, 2020-2034)

Adenocarcinoma

Gastric lymphoma

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Diagnostic Laboratories

Diagnostic Imaging

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5915

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Gastric Cancer Diagnostics Market Insights

4.1. Gastric Cancer Diagnostics Market - Market Snapshot
4.2. Gastric Cancer Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Global Incidence of Gastric Cancer
  - 4.2.1.2. Advancements in Diagnostic Technologies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Limited early detection methods
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Gastric Cancer Diagnostics Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Gastric Cancer Diagnostics Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
5.3. Reagents & Consumables
- 5.3.1. Global Gastric Cancer Diagnostics Market, by Reagents & Consumables, by Region, 2020-2034 (USD Billion)
5.4. Instruments
- 5.4.1. Global Gastric Cancer Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)

6. Global Gastric Cancer Diagnostics Market, by Disease Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
6.3. Adenocarcinoma
- 6.3.1. Global Gastric Cancer Diagnostics Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
6.4. Gastric lymphoma
- 6.4.1. Global Gastric Cancer Diagnostics Market, by Gastric lymphoma, by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gastric Cancer Diagnostics Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
7.4. Diagnostic Laboratories
- 7.4.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
7.5. Diagnostic Imaging
- 7.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Gastric Cancer Diagnostics Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Gastric Cancer Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Gastric Cancer Diagnostics Market - North America
- 8.3.1. North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
- 8.3.3. North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Gastric Cancer Diagnostics Market - U.S.
  - 8.3.4.1. U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Gastric Cancer Diagnostics Market - Canada
  - 8.3.5.1. Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
8.4. Gastric Cancer Diagnostics Market - Europe
- 8.4.1. Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.4.2. Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
- 8.4.3. Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Gastric Cancer Diagnostics Market - UK
  - 8.4.4.1. UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Gastric Cancer Diagnostics Market - France
  - 8.4.5.1. France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Gastric Cancer Diagnostics Market - Germany
  - 8.4.6.1. Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Gastric Cancer Diagnostics Market - Italy
  - 8.4.7.1. Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Gastric Cancer Diagnostics Market - Spain
  - 8.4.8.1. Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Gastric Cancer Diagnostics Market - Netherlands
  - 8.4.9.1. Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Gastric Cancer Diagnostics Market - Russia
  - 8.4.10.1. Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Gastric Cancer Diagnostics Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
8.5. Gastric Cancer Diagnostics Market - Asia Pacific
- 8.5.1. Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Gastric Cancer Diagnostics Market - China
  - 8.5.4.1. China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Gastric Cancer Diagnostics Market - India
  - 8.5.5.1. India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Gastric Cancer Diagnostics Market - Malaysia
  - 8.5.6.1. Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Gastric Cancer Diagnostics Market - Japan
  - 8.5.7.1. Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Gastric Cancer Diagnostics Market - Indonesia
  - 8.5.8.1. Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Gastric Cancer Diagnostics Market - South Korea
  - 8.5.9.1. South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Gastric Cancer Diagnostics Market - Australia
  - 8.5.10.1. Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Gastric Cancer Diagnostics Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
8.6. Gastric Cancer Diagnostics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Gastric Cancer Diagnostics Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Gastric Cancer Diagnostics Market - UAE
  - 8.6.5.1. UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Gastric Cancer Diagnostics Market - Israel
  - 8.6.6.1. Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Gastric Cancer Diagnostics Market - South Africa
  - 8.6.7.1. South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Gastric Cancer Diagnostics Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
8.7. Gastric Cancer Diagnostics Market - Latin America
- 8.7.1. Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Gastric Cancer Diagnostics Market - Mexico
  - 8.7.4.1. Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Gastric Cancer Diagnostics Market - Brazil
  - 8.7.5.1. Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Gastric Cancer Diagnostics Market - Argentina
  - 8.7.6.1. Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Gastric Cancer Diagnostics Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Agilent Technologies, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. AI Medical Service Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. BIOMERIEUX
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Bio-Rad Laboratories, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. F. Hoffmann-La Roche Ltd
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Illumina, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Mirxes Pte. Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Myriad Genetics, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. QIAGEN
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Vela Diagnostics
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development